Involvement of 15-lipoxygenase in the inflammatory arthritis

Journal of Cellular Biochemistry

Volumn 113, Issue 7, 2012, Pages 2279-2289

  Wu, Ming Yueh ^a   Lin, Tzu Hung ^a   Chiu, Yung Cheng ^b   Liou, Houng Chi ^a   Yang, Rong Sen ^a   Fu, Wen Mei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Arthritis; IL 1 ; lipoxygenase; metalloproteinase; TNF

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; ARACHIDONATE 15 LIPOXYGENASE; GELATINASE A; GLUCOCORTICOID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLAST; SYNOVIUM; WILD TYPE;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHROMONES; EICOSAPENTAENOIC ACID; FIBROBLASTS; FLUORENES; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROLINE; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84861022552     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24098     Document Type: Article

References (57)

1. Aarvak T, Natvig JB,. 2001. Cell-cell interactions in synovitis: Antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res 3: 13-17.
2. Andersson CK, Claesson HE, Rydell-Tormanen K, Swedmark S, Hallgren A, Erjefalt JS,. 2008. Mice lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. Am J Respir Cell Mol Biol 39: 648-656.
3. Angel J, Colard O, Chevy F, Fournier C,. 1993. Interleukin-1-mediated phospholipid breakdown and arachidonic acid release in human synovial cells. Arthritis Rheum 36: 158-167.
4. Asahara H, Asanuma M, Ogawa N, Nishibayashi S, Inoue H,. 1995. High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Int 37: 827-832.
5. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R,. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93: 7849-7854.
6. Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF,. 2000. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 165: 2790-2797.
7. Bomalaski JS, Clark MA,. 1993. Phospholipase A2 and arthritis. Arthritis Rheum 36: 190-198.
8. Carmona L, Cross M, Williams B, Lassere M, March L,. 2010. Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24: 733-745.
9. Catrina AI, Lampa J, Ernestam S, af Klint E, Bratt J, Klareskog L, Ulfgren AK,. 2002. Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) 41: 484-489.
10. Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL,. 2009. 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3t3-l1 adipocytes. Obesity 17: 1657-1663.
11. Chang X, Wei C,. 2011. Glycolysis and rheumatoid arthritis. Int J Rheum Dis 14: 217-222.
12. Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP, Ho KT, Hsu TC, Shiau MY,. 2008. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem 41: 955-959.
13. Chen B, Tsui S, Boeglin WE, Douglas RS, Brash AR, Smith TJ,. 2006. Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem 281: 18296-18306.
14. Cockett MI, Murphy G, Birch ML, O'Connell JP, Crabbe T, Millican AT, Hart IR, Docherty AJ,. 1998. Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 63: 295-313.
15. Ditzel HJ,. 2004. The K/BxN mouse: A model of human inflammatory arthritis. Trends Mol Med 10: 40-45.
16. Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL,. 2010. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 50: 115-131.
17. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J,. 2000. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 165: 5788-5797.
18. Gilman SC, Chang J, Zeigler PR, Uhl J, Mochan E,. 1988. Interleukin-1 activates phospholipase A2 in human synovial cells. Arthritis Rheum 31: 126-130.
19. Gilston V, Jones HW, Soo CC, Coumbe A, Blades S, Kaltschmidt C, Baeuerle PA, Morris CJ, Blake DR, Winyard PG,. 1997. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. Biochem Soc Trans 25: 518S.
20. Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D, II, Duray P, Schumacher RH, Jr., Yarboro CH, Klippel J, Kleiner D, El-Gabalawy HS,. 2000. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2: 145-153.
21. Honda S, Migita K, Hirai Y, Origuchi T, Yamasaki S, Kamachi M, Shibatomi K, Fukuda T, Kita M, Hida A, Ida H, Aoyagi T, Kawakami A, Kawabe Y, Oizumi K, Eguchi K,. 2001. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells. Clin Exp Immunol 126: 131-136.
22. Ishikawa T, Nishigaki F, Miyata S, Hirayama Y, Minoura K, Imanishi J, Neya M, Mizutani T, Imamura Y, Ohkubo Y, Mutoh S,. 2005. Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840. Eur J Pharmacol 508: 239-247.
23. Itoh T, Uzuki M, Shimamura T, Sawai T,. 2002. Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis. Ryumachi 42: 60-69.
24. Jayawickreme SP, Gray T, Nettesheim P, Eling T,. 1999. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells. Am J Physiol 276: L596-L603.
25. Jeon SG, Moon HG, Kim YS, Choi JP, Shin TS, Hong SW, Tae YM, Kim SH, Zhu Z, Gho YS, Kim YK,. 2009. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA. Clin Exp Allergy 39: 908-917.
26. Kayama Y, Minamino T, Toko H, Sakamoto M, Shimizu I, Takahashi H, Okada S, Tateno K, Moriya J, Yokoyama M, Nojima A, Yoshimura M, Egashira K, Aburatani H, Komuro I,. 2009. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 206: 1565-1574.
27. Kim EY, Moudgil KD,. 2009. The determinants of susceptibility/resistance to adjuvant arthritis in rats. Arthritis Res Ther 11: 239.
28. Kim C, Kim JY, Kim JH,. 2008. Cytosolic phospholipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep 41: 555-559.
29. Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ, Yang HI, Yoo MC,. 2011. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 31: 543-547.
30. Kleiner DE, Stetler-Stevenson WG,. 1999. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43 (Suppl): S42-S51.
31. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M,. 1999. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58: 691-697.
32. Korb A, Pavenstadt H, Pap T,. 2009. Cell death in rheumatoid arthritis. Apoptosis 14: 447-454.
33. Kronke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G, Zarbock A, Koenders MI, Axmann R, Zwerina J, Baenckler HW, van den Berg W, Voll RE, Kuhn H, Joosten LA, Schett G,. 2009a. 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 183: 3383-3389.
34. Kronke G, Uderhardt S, Katzenbeisser J, Schett G,. 2009b. The 12/15-lipoxygenase pathway promotes osteoclast development and differentiation. Autoimmunity 42: 383-385.
35. Laufer S,. 2003. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 15: 623-627.
36. Li P, Schwarz EM,. 2003. The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol 25: 19-33.
37. Liagre B, Vergne P, Rigaud M, Beneytout JL,. 1999. Arachidonate 15-lipoxygenase of reticulocyte-type in human rheumatoid arthritis type B synoviocytes and modulation of its activity by proinflammatory cytokines. J Rheumatol 26: 1044-1051.
38. Mahmoud RK, El-Ansary AK, El-Eishi HH, Kamal HM, El-Saeed NH,. 2005. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Ital J Biochem 54: 248-257.
39. McInnes IB, Schett G,. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7: 429-442.
40. Migita K, Eguchi K, Kawabe Y, Ichinose Y, Tsukada T, Aoyagi T, Nakamura H, Nagataki S,. 1996. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology 89: 553-557.
41. Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD,. 2002. Macrophage migration inhibitory factor in rheumatoid arthritis: Clinical correlations. Rheumatology (Oxford) 41: 558-562.
42. Moses MA,. 1997. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 15: 180-189.
43. Muller-Ladner U, Gay S,. 2002. MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction ? Ann Rheum Dis 61: 957-959.
44. Murphy G, Lee MH,. 2005. What are the roles of metalloproteinases in cartilage and bone damage ? Ann Rheum Dis 64 (Suppl 4): iv44-iv47.
45. Navarro E, Esteve M, Olive A, Klaassen J, Cabre E, Tena X, Fernandez-Banares F, Pastor C, Gassull MA,. 2000. Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids. J Rheumatol 27: 298-303.
46. Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK, III, Santos LL, Morand EF, David JR, Koch AE,. 2006. Macrophage migration inhibitory factor: A mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 8: R132.
47. Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S,. 2000. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43: 1226-1232.
48. Pearson CM, Wood FD,. 1963. Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am J Pathol 42: 73-95.
49. Prete PE, Gurakar-Osborne A, Kashyap ML,. 1995. Synovial fluid lipids and apolipoproteins: A contemporary perspective. Biorheology 32: 1-16.
50. Pruzanski W, Vadas P, Stefanski E, Urowitz MB,. 1985. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol 12: 211-216.
51. Rooney M, Whelan A, Feighery C, Bresnihan B,. 1989. The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis. J Rheumatol 16: 459-467.
52. Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P,. 2009. Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice. Arthritis Res Ther 11: R138.
53. Walsh DA,. 1999. Angiogenesis and arthritis. Rheumatology (Oxford) 38: 103-112.
54. Walters JN, Bickford JS, Beachy DE, Newsom KJ, Herlihy JD, Peck MV, Qiu X, Nick HS,. 2011. cPLA(2)alpha gene activation by IL-1beta is dependent on an upstream kinase pathway, enzymatic activation and downstream 15-lipoxygenase activity: A positive feedback loop. Cell Signal 23: 1944-1951.
55. Wang Y, Yang L, Zhang J, Xue R, Tang Z, Huang W, Jiang D, Tang X, Chen P, Sung KL,. 2010. Differential MMP-2 activity induced by mechanical compression and inflammatory factors in human synoviocytes. Mol Cell Biomech 7: 105-114.
56. Wittwer J, Hersberger M,. 2007. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 77: 67-77.
57. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y,. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59: 455-461.